Pharmacokinetics and Pharmacogenetics of Dabigatran
Dabigatran etexilate is a prodrug of dabigatran, a oral direct inhibitor of thrombin. Pharmacokinetics of dabigatran etexilate doesn't have the disadvantages of vitamin K antagonists. However, pharmacokinetics and pharmacogenetics of dabigatran are variable. This can affect both effectiveness a...
Saved in:
Main Authors: | A. V. Savinova (Author), V. S. Dobrodeeva (Author), M. M. Petrova (Author), R. F. Nasyrova (Author), N. A. Shnayder (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics and Pharmacogenetics of Apixaban
by: A. V. Savinova, et al.
Published: (2020) -
Role of Pharmacogenetic Testing in the Risk and Safety Assessment of Valproates: The Ethnic Aspect (Review)
by: N. A. Shnayder, et al.
Published: (2024) -
Pharmacogenetics-Informed Pharmacometabolomics as an Innovative Approach to Assessing the Safety and Risk of Pharmacotherapy with Valproic Acid
by: N. A. Shnayder, et al.
Published: (2023) -
Antipsychotic-Induced QT Prolongation and Torsade de Pointes in Patients with Mental Disorders: A Review
by: R. F. Nasyrova, et al.
Published: (2022) -
Effects of Simvastatin on Pharmacokinetics and Anticoagulant Effects of Dabigatran in Healthy Subjects
by: Hyewon Chung, et al.
Published: (2023)